Potential virulence role of the Legionella pneumophila ptsP orthologHIGA, Futoshi; EDELSTEIN, Paul H.Infection and immunity. 2001, Vol 69, Num 8, pp 4782-4789, issn 0019-9567Article

Specificity of Ertapenem Susceptibility Screening for Detection of Klebsiella pneumoniae CarbapenemasesMCGETTIGAN, Shannon E; ANDREACCHIO, Kathleen; EDELSTEIN, Paul H et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 3, pp 785-786, issn 0095-1137, 2 p.Article

Comparison of the Plating Efficiencies and Shelf Lives of Three Different Commercial Buffered Charcoal Yeast Extract Media Supplemented with α-Ketoglutaric AcidEDELSTEIN, Paul H; EDELSTEIN, Martha A. C.Journal of clinical microbiology (Print). 2010, Vol 48, Num 5, pp 1882-1883, issn 0095-1137, 2 p.Article

Bacterial pneumonia - Pathogenesis, pathogens, diagnosis, and treatmentEDELSTEIN, Paul H.Clinical infectious diseases. 1995, Vol 21, issn 1058-4838, 77 p., SUP3Conference Proceedings

Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: Molecular mechanisms and resistance phenotypesEDELSTEIN, Paul H.Clinical infectious diseases. 2004, Vol 38, pp 322-327, issn 1058-4838, 6 p., SUP4Article

The management of pneumonia in children in developing countriesSHANN, F.Clinical infectious diseases. 1995, Vol 21, pp S218-S225, issn 1058-4838, SUP3Conference Paper

Legionella maceachernii pneumonia in a patient with HIV infectionDUMOFF, Kimberly; MCGOVERN, Paul C; EDELSTEIN, Paul H et al.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 2, pp 141-145, issn 0732-8893, 5 p.Article

Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumoniaEDELSTEIN, Paul H; WEISS, William J; EDELSTEIN, Martha A. C et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 2, pp 533-540, issn 0066-4804, 8 p.Article

Fluoroquinolone-Resistant Pseudomonas aeruginosa in Chronic RhinosinusitisGUSS, Joel; DOGHRAMJI, Laurel; EDELSTEIN, Paul H et al.ORL. 2009, Vol 71, Num 5, pp 263-267, issn 0301-1569, 5 p.Article

The Streptococcus milleri group as a cause of pulmonary infectionsSHINZATO, T; SAITO, A.Clinical infectious diseases. 1995, Vol 21, pp S238-S243, issn 1058-4838, SUP3Conference Paper

Coxiella burnetii (Q fever) pneumoniaMARRIE, T. J.Clinical infectious diseases. 1995, Vol 21, pp S253-S264, issn 1058-4838, SUP3Conference Paper

In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophilaEDELSTEIN, Paul H; BAOFENG HU; EDELSTEIN, Martha A. C et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 6, pp 2533-2535, issn 0066-4804, 3 p.Article

Pneumonia due to Chlamydia pneumoniae : prevalence, clinical features, diagnosis, and treatmentKAUPPINEN, M; SAIKKU, P.Clinical infectious diseases. 1995, Vol 21, pp S244-S252, issn 1058-4838, SUP3Conference Paper

In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumoniaEDELSTEIN, Paul H; HIGA, F; EDELSTEIN, Martha A. C et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 10, pp 2685-2690, issn 0066-4804Article

BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigsEDELSTEIN, Paul H; SHINZATO, Takashi; EDELSTEIN, Martha A. C et al.Journal of antimicrobial chemotherapy (Print). 2001, Vol 48, Num 5, pp 667-675, issn 0305-7453Article

Antimicrobial chemotherapy for Legionnaire's disease : a reviewEDELSTEIN, P. H.Clinical infectious diseases. 1995, Vol 21, pp S265-S276, issn 1058-4838, SUP3Conference Paper

Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infectionsLAUTENBACH, Ebbing; FISHMAN, Neil O; BILKER, Warren B et al.Archives of internal medicine (1960). 2002, Vol 162, Num 21, pp 2469-2477, issn 0003-9926, 9 p.Article

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniaeLAUTENBACH, Ebbing; STROM, Brian L; BILKER, Warren B et al.Clinical infectious diseases. 2001, Vol 33, Num 8, pp 1288-1294, issn 1058-4838Article

Risk Factors for Infection or Colonization with CTX-M ExtendedSpectrum-β-Lactamase-Positive Escherichia coliHAN, Jennifer H; KASAHARA, Kei; EDELSTEIN, Paul H et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 11, pp 5575-5580, issn 0066-4804, 6 p.Article

Prevalence of CTX-M β-Lactamases in Philadelphia, PennsylvaniaMCGETTIGAN, Shannon E; BAOFENG HU; ANDREACCHIO, Kathleen et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 9, pp 2970-2974, issn 0095-1137, 5 p.Article

Legionella pneumophila NudA is a nudix hydrolase and virulence factorEDELSTEIN, Paul H; BAOFENG HU; SHINZATO, Takashi et al.Infection and immunity. 2005, Vol 73, Num 10, pp 6567-6576, issn 0019-9567, 10 p.Article

The molecular basis of pneumococcal infection : a hypothesisCUNDELL, D; MASURE, H. R; TUOMANEN, E. I et al.Clinical infectious diseases. 1995, Vol 21, pp S204-S212, issn 1058-4838, SUP3Conference Paper

The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremiaHAN, Jennifer H; EDELSTEIN, Paul H; BILKER, Warren B et al.The Journal of infection. 2013, Vol 66, Num 1, pp 41-47, issn 0163-4453, 7 p.Article

Effect of Reduced Vancomycin Susceptibility on Clinical and Economic Outcomes in Staphylococcus aureus BacteremiaHAN, Jennifer H; MASCITTI, Kara B; EDELSTEIN, Paul H et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 10, pp 5164-5170, issn 0066-4804, 7 p.Article

Fatal Kytococcus schroeteri Infection With Crusted Papules and Distinctive Histologic Plump TetradsNAGLER, Arielle R; WANAT, Karolyn A; BACHMAN, Michael A et al.Archives of dermatology (1960). 2011, Vol 147, Num 9, pp 1119-1121, issn 0003-987X, 3 p.Article